My Trading Account β†’
β–Ύ
Trading Profile Active
Active Trader
Verified Trader
⚑ My $100K Trading Account β†’ β˜… My Saved Watchlist β†’
🟒 My $100K Account β†’ Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts

Crescent Capital BDC Inc. (CCAP) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$9.41 +1.56% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.42

Crescent Capital BDC Inc. (CCAP) carries a Roarable Rating of D (Sell) with 51/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D β€’ SELL / AVOID Cap $346.9M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CCAP Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Crescent Capital BDC Inc. (NASDAQ: CCAP) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $9.41 (+1.56% 1D, market cap $346.9M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CCAP ranks #626 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does CCAP compare to GEMI and RM in the Financials sector?
β–Ό

Within the Financials sector (Finance: Consumer Services), CCAP carries a Roarable D (51/100 RQD), trailing P/E of 9.9x, gross margin of β€”, and ROIC of -11.1%. By comparison, GEMI (Gemini Space Station Inc. (Class A)) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $347.9M) and RM (Regional Management Corp.) posts a C- grade (61/100 RQD, P/E 7.5x, ROIC 11.9%, cap $350.8M). Among the 5-stock peer group, RM leads on earnings multiple (7.5x) while RM leads on capital efficiency (11.9% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CCAP?
β–Ό

Per CCAP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001633336), Crescent Capital BDC Inc. generated $276.3M in revenue (-7.6% YoY), $34.5M in net income, and $74.7M in free cash flow against $1.62B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $9.42 (+0.09%)🧬 Cannibal Buyback (-1.80% YoY Shares)βš™οΈ Cash Engine: 11/20 (D+) β€’ 27% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY β€’ 49.7% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510051
Quant Analyst Panel Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D Β· Rk D+
Cash (11)Whales (5)SEC (13)Macro (8)CEO (14)
Each axis scored 0–20
12M PRICE TARGET CONE-3.2% Base Target
$16 Bull$9 Base$7 Bear
πŸ“¬ FREE CCAP RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for CCAP)Realized 20D OHLCV Swing Band: Β±5%
Deterministic 5-Pillar Attribution (51/100 Composite)
πŸ” WHY CCAP SCORES 51/100 (D) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Insider Conviction & Share Dilution+14/20 pts (27% of score)

SEC Form 4 / 13F Thermometer: 70% Net Buy β€’ Cannibal Buyback (-1.80% YoY Shares)

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 4/9

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
43
Grade D$8.96-5.1% Next Q
Q2 (-2Q)
46
Grade D$8.50+6% Next Q
Q3 (-1Q)
48
Grade D$9.01+4.4% Next Q
Current
51
Grade D$9.41-1.3% Hist 90D Ξ±
Trajectory: D (43) β†’ D (51)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a CCAP Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While CCAP currently carries a cautious 51/100 (D) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.51) and Max Pain ($9.88) forces dealer call-delta covering toward $15.94.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CCAPβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œCCAP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How CCAP Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$74.7M (27% FCF Margin)
Revenue$276.3MGross Profit $143.7M (52%)Cost of Sales $132.6MOp Profit $0 (0%)OpEx (R&D/SG&A) $143.7MNet Profit$34.5M (12.5%)Tax/Other $0

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $280.8M
FY24
Rev $299.0M
FY25
Rev $276.3M
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$276.3M52%-35.7%$34.5M$74.7M-11.1%
FY 2024$299.0M52%-35.7%$73.6M$58.9M-11.5%
FY 2023$280.8M52%-35.7%$83.8M$92.3M-11.1%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CCAP)

  • βœ“Walkthrough of CCAP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CCAP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -32.40%πŸ“ HORIZONTAL RANGE
2026-11-04O $9.27H $9.41L $9.27C $9.41VOL 103.0K
RES: $12.26SUP: $8.04SMA50: $9.51SMA200: $11.63
$14.55$12.89$11.22$9.55$7.88RES $12.26SUP $8.04$9.412026-05-052026-06-182026-08-052026-09-212026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CCAP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
-1.4%/yr Implied 5Y Growth

vs. -7.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CCAP today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for CCAP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CCAP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CCAP)

1. Head-to-Head Financials Peer Comparison (CCAP vs. GEMI, RM, BRBI, TREE)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, Crescent Capital BDC Inc. (CCAP) ranks #626 by composite RQD confidence (51/100, grade D) and #782 by equity capitalization ($346.9M). Within this direct 5-issuer industry benchmark cohort, RM leads on earnings valuation at 7.5x trailing P/E, while RM leads on capital efficiency and profitability with 11.9% ROIC and β€” gross margin. RM currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with CCAP at 51/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CCAP ACTIVE
Crescent Capital BDC Inc.
D 51/100 9.9x β€” -11.1% +1.56% $346.9M Benchmark Subject
GEMI
Gemini Space Station Inc. (Class A)
E 24/100 β€” β€” -35.0% -7.49% $347.9M /gemi-vs-ccap β†’
RM
Regional Management Corp.
C- 61/100 7.5x β€” 11.9% +8.02% $350.8M /rm-vs-ccap β†’
BRBI
BRBI BR Partners S.A. ADSs
D 45/100 β€” β€” β€” +3.55% $366.0M /brbi-vs-ccap β†’
TREE
LendingTree Inc.
D 50/100 β€” β€” 8.6% -3.08% $380.2M /tree-vs-ccap β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001633336 β†—

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Crescent Capital BDC Inc. (CCAP) reported GAAP revenue of $276.3M (-7.6% vs. FY2024 revenue of $299.0M , and -1.6% cumulative change since FY2023) , GAAP net income of $34.5M, operating cash flow of $74.7M, and free cash flow of $74.7M (+26.8% YoY). On the balance sheet, CCAP closed FY2025 with $1.62B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $276.3M $34.5M $74.7M $74.7M $1.62B β€”
FY2024 (FY) 2024-12-31 $299.0M $73.6M $58.9M $58.9M $1.66B β€”
FY2023 (FY) 2023-12-31 $280.8M $83.8M $92.3M $92.3M β€” β€”

3. CCAP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Crescent Capital BDC Inc. (NASDAQ: CCAP) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $9.41 (+1.56% 1D, market cap $346.9M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CCAP ranks #626 in composite RQD confidence.

How does CCAP compare to GEMI and RM in the Financials sector?

Within the Financials sector (Finance: Consumer Services), CCAP carries a Roarable D (51/100 RQD), trailing P/E of 9.9x, gross margin of β€”, and ROIC of -11.1%. By comparison, GEMI (Gemini Space Station Inc. (Class A)) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $347.9M) and RM (Regional Management Corp.) posts a C- grade (61/100 RQD, P/E 7.5x, ROIC 11.9%, cap $350.8M). Among the 5-stock peer group, RM leads on earnings multiple (7.5x) while RM leads on capital efficiency (11.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CCAP?

Per CCAP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001633336), Crescent Capital BDC Inc. generated $276.3M in revenue (-7.6% YoY), $34.5M in net income, and $74.7M in free cash flow against $1.62B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CCAP trading relative to its 50-day, 200-day, and 52-week technical levels?

CCAP last traded at $9.41 (+1.56% on volume of 103,027 shares), positioning the stock -1.05% below its 50-day simple moving average ($9.51) and -19.09% below its 200-day simple moving average ($11.63). Across its 52-week range of $8.40 to $15.18, CCAP sits at the 14.9% percentile with a 14-day RSI of 57.5 (BULLISH MOMENTUM) and an implied next-earnings move of Β±5.0% ($8.94 to $9.88).

ROARABLE RATING BRIEF β€’ RQD 51/100 (D) βœ“ SEC XBRL & RQD VERIFIED

CCAP β€” Crescent Capital BDC Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Crescent Capital BDC Inc. (CCAP) earns a live Roarable RQD composite score of 51/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $9.41 (+1.56% 1D, market capitalization $346.9M).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of -11.1%, gross margin of β€”, operating margin of β€”, and free cash flow yield of 21.81%.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (14/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Crescent Capital BDC Inc. (CCAP) is a NASDAQ-listed operating company in the Finance: Consumer Services industry (Financials sector) with an equity market capitalization of $341.6M. The business operates with a gross margin of 0%, an operating margin of 0%, and a return on invested capital (ROIC) of -11.1% (free cash flow yield of 21.81%). Within the Finance: Consumer Services peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Crescent Capital BDC Inc. (CCAP) reported $276.3M in annual revenue (up from $299.0M in FY2024, -7.6% YoY) and $34.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($280.8M revenue, $83.8M net income) through FY2025, CCAP scaled operating cash flow to $74.7M and free cash flow to $74.7M, backed by $1.62B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (D β€’ RQD 51/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 21.81% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $8.40 – $15.18 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 9.9x trailing P/E against β€” operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Finance: Consumer Services (Financials), CCAP carries a macro regime beta of 1.00 and gross margin of β€”.

  • Key Question #1: Can CCAP sustain or expand its β€” operating margin and -11.1% ROIC against Finance: Consumer Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $276.3M and free cash flow of $74.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is CCAP's 9.2x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

CCAP Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Crescent Capital BDC Inc. (CCAP) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to CCAP Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CCAP Bull vs. Bear Conversation Board β€” What's Your Call at $9.41?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CCAP 🐻 33% BEARISH CONVICTION
1. Pick Your Side on CCAP:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MA MacroHawk_NYC RQD DEBATE OPENER β€’ Cross-Asset Macro Desk πŸ‚ BULLISH 🎯 Target: $10.66 (+15.0%)
πŸ“Œ Pinned Debate

A 21.81% FCF yield and a 9.9 trailing P/E suggest the cash generation may be undervalued relative to reported earnings.

A 21.81% FCF yield and a 9.9 trailing P/E suggest the cash generation may be undervalued relative to reported earnings.. When you look under the hood at CCAP, Fundamental Cash Engine is 11/20 with 0.0% gross margins and -11.1% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (5/20) has been quietly accumulating below $15.18. My 12M target is $10.66.

EarningsSniper πŸ‚ BULL

Both sides have a point here β€” CCAP's 13/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

MU MultipleCompression RQD DEBATE OPENER β€’ Valuation Discipline 🐻 BEARISH 🎯 Target: $7.14 (-23.0%)
Spot @ $9.27

A -11.1% ROIC, zero reported revenue, and a D+ RQD score point to weak fundamentals and limited macro tailwind.

A -11.1% ROIC, zero reported revenue, and a D+ RQD score point to weak fundamentals and limited macro tailwind.. Look at the math on CCAP: paying 9.9x trailing P/E for -11.1% ROIC and 0.0% operating margins leaves zero margin of safety if Finance: Consumer Services demand softens. I'd wait for a retest of $8.16 before getting long.

LIVE TAPE